Business · 19/01/2017Updated: 10/17/2026 · 1 min read
FDA Reopens Comment Period on Manufacturer Communications Regarding Unapproved Medical Products
The FDA is reopening the comment period for a public hearing on its review of regulations regarding manufacturer communications about unapproved medical products, and has released a new memorandum and draft guidance documents to inform the discussion.